Dermapharm Holding SE (FRA:DMP)

Dermapharm Holding SE Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,195	1,150	1,040	959.6	807.64
Other Revenue	0.75	0.42	0.25	0.49	0.67
Revenue	1,195	1,151	1,041	960.09	808.31
Revenue Growth (YoY)	3.89%	10.59%	8.38%	18.78%	13.15%
Cost of Revenue	445.6	446.6	391.85	349.87	354.42
Gross Profit	749.85	704.14	648.7	610.22	453.89
Selling, General & Admin	287.43	271.01	190.56	168.95	158.06
Other Operating Expenses	158.18	151.21	117.72	99.68	110.13
Operating Expenses	527.78	510.99	365.98	314.31	313.77
Operating Income	222.07	193.16	282.72	295.91	140.12
Interest Expense	-58.41	-54.97	-12.34	-8.84	-9.36
Interest & Investment Income	13.99	2.49	0.33	4.02	0.51
Earnings From Equity Investments	1.52	-7.16	-13.54	0.32	-1.5
Currency Exchange Gain (Loss)	1.4	-1.95	0.37	2.28	-1.63
Other Non Operating Income (Expenses)	-0.96	-16.63	-1.12	-0.83	0.24
EBT Excluding Unusual Items	179.61	114.93	256.43	292.86	128.38
Merger & Restructuring Charges	-	-	-	-0.6	-
Impairment of Goodwill	-2.12	-	-36.45	-5.43	-
Gain (Loss) on Sale of Investments	-0	-1.98	-	9.06	-
Gain (Loss) on Sale of Assets	0.63	2.96	3.13	1.38	0.23
Asset Writedown	-6.21	-15.82	-7.03	-4.48	-3.58
Other Unusual Items	-	5.78	-	-	-
Pretax Income	172.01	106	216.3	292.98	125.28
Income Tax Expense	60.27	45.46	83.68	84.07	39.36
Earnings From Continuing Operations	111.74	60.53	132.62	208.9	85.93
Minority Interest in Earnings	2.05	1.83	1.62	0.68	-0.1
Net Income	113.79	62.37	134.24	209.58	85.83
Net Income to Common	113.79	62.37	134.24	209.58	85.83
Net Income Growth	82.45%	-53.54%	-35.95%	144.19%	11.18%
Shares Outstanding (Basic)	54	54	54	54	54
Shares Outstanding (Diluted)	54	54	54	54	54
EPS (Basic)	2.11	1.16	2.49	3.89	1.59
EPS (Diluted)	2.11	1.16	2.49	3.89	1.59
EPS Growth	82.45%	-53.54%	-35.91%	144.65%	11.19%
Free Cash Flow	163.14	177.88	249.52	189.17	90.3
Free Cash Flow Per Share	3.03	3.30	4.63	3.51	1.68
Dividend Per Share	0.900	0.880	1.050	2.170	0.880
Dividend Growth	2.27%	-16.19%	-51.61%	146.59%	10.00%
Gross Margin	62.72%	61.19%	62.34%	63.56%	56.15%
Operating Margin	18.58%	16.79%	27.17%	30.82%	17.34%
Profit Margin	9.52%	5.42%	12.90%	21.83%	10.62%
Free Cash Flow Margin	13.65%	15.46%	23.98%	19.70%	11.17%
EBITDA	250.77	220.31	302.36	312.36	155.05
EBITDA Margin	20.98%	19.14%	29.06%	32.53%	19.18%
D&A For EBITDA	28.7	27.15	19.64	16.45	14.92
EBIT	222.07	193.16	282.72	295.91	140.12
EBIT Margin	18.58%	16.79%	27.17%	30.82%	17.34%
Effective Tax Rate	35.04%	42.89%	38.69%	28.70%	31.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.